Black Diamond Therapeutics remains undervalued despite recent share price gains, with a promising EGFR inhibitor pipeline ...
The ASX small-cap market extended its losing streak this week, with the S&P/ASX Small Ordinaries Index (XSO) slipping 108 points, or 2.98%, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback